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Abstract
Introduction:  Colorectal  cancer  presents  itself  as  acute  bowel  occlusion  in  10--40%  of  patients.
There are  two  main  therapeutic  approaches:  urgent  surgery  and  endoluminal  placement  self-
expandable  metallic  stents  (SEMS).
Aims  and  Methods:  This  study  intended  to  better  clarify  the  risk/beneﬁt  ratio  of  the  above-
mentioned  approaches.  We  conducted  a  retrospective  longitudinal  multicenter  study,  including
189 patients  with  acute  malignant  colorectal  occlusion,  diagnosed  between  January  2005  and
March 2013.
Results:  Globally  (85  patients  --  35  bridge-to-surgery  and  50  palliative),  SEMS’s  technical  suc-
cess was  of  94%.  Palliative  SEMS  had  limited  clinical  success  (60%)  and  were  associated  with
40% of  complications.  SEMS  occlusion  (19%)  was  the  most  frequent  complication,  followed  by
migration (9%)  and  bowel  perforation  (7%).  Elective  surgery  after  stenting  was  associated  with  a
higher frequency  of  primary  anastomosis  (94%  vs.  76%;  p  =  0.038),  and  a  lower  rate  of  colostomy
(26% vs.  55%;  p  =  0.004)  and  overall  mortality  (31%  vs.  57%;  p  =  0.02).  However,  no  signiﬁcant
differences  were  identiﬁed  concerning  postoperative  complications.  Regarding  palliative  treat-
ment, no  difference  was  found  in  the  complications  rate  and  overall  mortality  between  SEMS
and decompressive  colostomy/ileostomy.  In  this  SEMS  subgroup,  we  found  a  higher  rate  of  rein-
terventions  (40%  vs.  5%;  p  =  0.004)  and  a  longer  hospital  stay  (14,  nine  vs.  seven,  three  days;
p =  0.004).
Conclusion:  SEMS  placement  as  a  bridge-to-surgery  should  be  considered  in  the  acute  treatment
of colorectal  malignant  occlusion,  since  it  displays  advantages  regarding  primary  anastomosis,
colostomy  rate  and  overall  mortality.  In  contrast,  in  this  study,  palliative  SEMS  did  not  appear
to present  signiﬁcant  advantages  when  compared  to  decompressive  colostomy.uesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.U.
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Tratamento  Agudo  da  Oclusão  Colorrectal  Maligna:  Prática  na  Vida  Real
Resumo
Introduc¸ão:  O  cancro  colorrectal  manifesta-se  como  oclusão  intestinal  aguda  em  10--40%  dos
doentes. Existem  duas  abordagens  terapêuticas  principais:  cirurgia  de  urgência  e  prótese  endo-
luminal.
Objectivo  e  Métodos:  Este  estudo  teve  como  objetivo  clariﬁcar  o  risco/benefício  das  aborda-
gens mencionadas.  Foi  realizado  um  estudo  multicêntrico,  retrospetivo  longitudinal,  que  incluiu
189 doentes  com  oclusão  colorrectal  maligna  aguda,  diagnosticados  entre  janeiro  de  2005  e
marc¸o de  2013.
Resultados:  Globalmente  (85  pacientes  --  35  como  ponte  para  cirurgia  e  50  como  paliac¸ão)
a colocac¸ão  de  prótese  teve  sucesso  técnico  de  94%.  As  próteses  paliativas  apresentaram
sucesso clínico  limitado  (60%)  e  associaram-se  a  40%  de  complicac¸ões.  A  oclusão  tumoral  da
prótese (19%)  foi  a  complicac¸ão  mais  frequente,  seguindo-se  a  migrac¸ão  (9%)  e  a  perfurac¸ão
intestinal  (7%).  A  cirurgia  eletiva  após  colocac¸ão  de  prótese  associou-se  a  maior  frequência  de
anastomoses  primárias  (94%  vs  76%;  p  =  0.038)  e  a  menores  taxas  de  colostomia  (26%  vs  55%;
p =  0.004)  e  mortalidade  (31%  vs  57%;  p  =  0.02).  Contudo,  não  houve  diferenc¸as  signiﬁcativas
nas complicac¸ões  pós-cirúrgicas.  No  tratamento  paliativo,  a  prótese  e  a  colostomia/ileostomia
descompressiva  não  apresentaram  diferenc¸as  signiﬁcativas  nas  complicac¸ões  ou  mortalidade.
Neste subgrupo  de  próteses,  observou-se  elevada  taxa  de  reintervenc¸ão  (40%  vs  5%;  p  =  0.004)
e de  tempo  de  internamento  (14,9  vs  7,3  dias;  p  =  0.004).
Conclusão:  A  colocac¸ão  de  prótese  como  ponte  para  a  cirurgia  deve  ser  considerada  no  trata-
mento agudo  da  oclusão  maligna  colorrectal,  pois  apresenta  vantagens  nas  taxas  de  anastomoses
primárias,  colostomias  e  mortalidade.  Em  contraste,  neste  estudo  as  próteses  paliativas  não
apresentaram  vantagem  clínica  signiﬁcativa  em  comparac¸ão  à  colostomia  descompressiva.
© 2015  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.U.  Este  é
um artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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center  study,  involving  two  hospitals:  Braga  Hospital  and1. Introduction
Colorectal  cancer  (CRC)  is  the  fourth  most  common  tumor
worldwide1 and  one  of  the  cancers  with  the  highest  inci-
dence  and  mortality  in  Portugal.2
CRC  presents  itself  as  acute  intestinal  occlusion  in
10--40%  of  patients.1,3--9 This  is  more  common  when  the
tumor  is  located  in  the  left  colon4 and  results  in  a  higher
postoperative  mortality  (12%)  when  compared  to  non-
occlusive  tumors  (3.5%).10
Currently,  there  are  two  main  approaches  for  acute
decompression:  the  traditional  urgent  surgery  and  the
endoluminal  placement  of  self-expandable  metallic  stents
(SEMS).3,4,11--13 Urgent  surgical  resection  usually  involves  a
defunctioning  stoma  with  or  without  primary  resection  of
the  obstructing  tumor.  Additionally,  it  is  associated  with
a  high  mortality  (15--34%)  and  morbidity  (15--64%)  when
compared  to  elective  surgery  (0.9--6%).1,3,11,14--16 Therefore,
non-surgical  approaches  have  been  proposed  as  an  alterna-
tive.  Among  them,  SEMS  placement  has  been  increasingly
used  for  the  relief  of  colonic  occlusion  symptoms,  since  its
ﬁrst  application  in  the  early  1990s.
The  endoluminal  endoscopic  approach  is  theoretically
advantageous,  allowing  the  circumvention  of  an  emergency
surgical  intervention  which,  besides  the  already  mentioned
implications,  results  in  a  permanent  colostomy  in  50--66%
of  cases.1,3,4,11,14,16 Additionally,  it  allows  palliative  treat-
ment  without  any  surgical  intervention.3,4,12,15,17 Thus,  SEMS
placement  can  be  used  as  a  bridge  to  elective  surgery
U
a
wn  patients  with  potential  for  curative  resection  or  pallia-
ive  treatment  in  patients  who  cannot  undergo  surgery  or
ith  advanced  disease.  However,  SEMS  placement  also  has
omplications  (21.0--34.4%),5,8,16 namely  bowel  perforation
1.2--13%),  migration  (1.2--11.8%)  and  reocclusion  by  tumor
ngrowth  (1.8--9%).3,7,8,16,18 Moreover,  SEMS  does  not  appear
o  provide  a signiﬁcant  improvement  in  the  overall  survival
r  in  the  long  term  prognosis.13,14,19
Many  investigations  have  tried  to  compare  SEMS  vs.
urgery.  However,  the  reported  results  are  diverse,  the  ran-
omized  studies  are  scarce  and  globally  the  population
amples  per  study  are  small  and  have  varying  criteria  for
utcomes  measurement.  With  this  study,  we  aim  to  clarify
he  risk/beneﬁt  ratio  of  these  approaches  in  real  clinical
ractice,  comparing:  (a)  SEMS  placement  with  curative  and
alliative  purposes;  (b)  SEMS  placement  as  bridge-to-surgery
s.  urgent  surgery  (curative  purpose);  (c)  SEMS  placement
s.  urgent  surgery  (palliative  purpose).
.  Aims and methods
.1.  Study  design
his  is  a  retrospective  longitudinal  nonrandomized  multi-nidade  Local  de  Saúde  do  Alto  Minho  (ULSAM).  We  studied
ll  patients  with  acute  malignant  colorectal  occlusion  that
ere  treated  by  stenting  or  surgery  between  January  2005
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nd  March  2013.  Patients’  data  were  collected  by  analyz-
ng  all  clinical,  endoscopic,  radiologic  and  surgical  reports
manual  and  electronic  records).
The  inclusion  criteria  were:  an  acute  colorectal  occlu-
ion  caused  by  colorectal  malignancy  which  underwent  SEMS
lacement  or  urgent  surgery,  in  the  determined  period.
atients  with  incomplete  data  or  admitted  with  clinical
ymptoms  of  bowel  perforation  were  excluded  from  the
tudy.
.2.  Colorectal  occlusion  diagnosis  and
anagement
iagnosis  of  acute  colorectal  occlusion  was  based  on  clas-
ical  clinical  and  imaging  ﬁndings:  abdominal  distension
nd  pain,  nausea  and  vomiting  without  normal  emission
f  stool  or  air  and  a  dilated  colon  in  the  abdominal
adiography.  Malignant  origin  and  tumor  location  were
etermined  using  ﬂexible  sigmoidoscopy  or  abdominal  com-
uterized  tomography  and  conﬁrmed  by  biopsy/specimen
valuation.  Patients  then  underwent  either  endoscopic
tenting  or  urgent  surgery,  according  to  the  availability
f  resources  at  each  moment  and  clinical  particularities.
efore  acute  therapeutic  procedures,  some  patients  already
ad  a  presumptive  orientation  --  possible  curative  or  pallia-
ive  purpose.
.3.  Stenting
EMS  placement  was  performed  by  experienced  endo-
copists  (>20  procedures)  in  both  hospitals,  according  to  the
enerally  accepted  procedure  --  usually  through-the-scope
sing  a  double  channel  therapeutic  endoscope  under  ﬂuoro-
copic  guidance  or  direct  endoscopic  vision  if  the  stricture
ould  be  previously  crossed  with  an  ultra-slim  endoscope.
ive  types  of  uncovered  colonic  stents  were  used,  according
o  the  hospital’s  availability,  with  no  pre-dilation:  Wallﬂex®,
allstent® and  Ultraﬂex® (Boston  Scientiﬁc),  Evolution®
Cook  Medical)  and  Hanarostent® (MITec).  After  SEMS  place-
ent,  immediate  signs  of  decompression  were  once  again
valuated  and  clinical  examination  and  a  plain  abdominal
adiography  were  usually  repeated  to  assess  the  procedure’s
uccess  and  exclude  complications.
.4.  Urgent  surgery
rgent  surgery  was  performed  through  laparotomy  and  the
ype  of  operation  was  determined  based  on  tumor  location,
atient’s  general  condition  and  the  surgeon’s  experience.
he  surgical  options  included:  one-stage  procedure  with
rimary  anastomosis;  two-stage  procedure  with  segmentec-
omy  and  terminal  colostomy  (Hartmann’s  procedure)  or
egmentectomy  with  primary  anastomosis  and  protecting
stomy;  and  three-stage  procedure  such  as  loop  colostomy
ollowed  by  segmentectomy  maintaining  the  protective
olostomy,  to  be  closed  at  a  later  date.After  having  acute  treatment,  patients  received  support-
ve  care  and  adequate  disease  staging  in  order  to  decide
he  treatment  purpose  (curative  vs.  palliative).  This  decision
as  performed  by  an  oncological  decision  group.  According
P
d
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o  their  general  condition,  patients  underwent  other  treat-
ents  such  as  elective  surgery,  chemotherapy  and  radiation
herapy.  However,  most  of  these  were  not  in  the  scope  of
his  work.
.5.  Study  variables  and  outcomes
atients’  data  were  collected  from  the  acute  event  until
he  last  follow-up.  Two  main  population  groups  were  cre-
ted,  the  ‘‘SEMS  placement  group’’  and  the  ‘‘Urgent  surgery
roup’’;  then  each  one  was  divided  into  two  subgroups
ccording  to  the  treatment  purpose  --  ‘‘curative’’  and
‘palliative’’.  Baseline  characteristics  and  outcomes  of  the
rocedure  were  documented  and  compared  with  the  two
ajor  population  groups  studied.
Technical  success  in  SEMS  was  deﬁned  as  the  successful
lacement  of  the  stent  across  the  malignant  stricture  allow-
ng  for  patency.  Clinical  success  was  achieved  when  there
as  colonic  decompression  with  obstructive  symptom  relief
nd  without  any  complications  requiring  endoscopic  or  surgi-
al  reintervention.  Patency  (mainly  for  stent  palliation)  was
eﬁned  as  the  period  (in  days)  between  SEMS  placement
nd  recurrence  of  obstructive  symptoms  or  until  a  patient
as  lost  in  the  follow-up  or  died.  In  SEMS  bridge-to-surgery
roup,  the  time  for  surgery  was  deﬁned  as  the  number  of
ays  between  SEMS  placement  and  elective  surgery.
Complications  were  deﬁned  as  any  adverse  event  related
o  SEMS  placement  or  urgent  surgery,  leading  to  hospital
eadmission  or  prolonging  the  current  hospital  stay.  Early
nd  late  complications  were  considered,  as  they  occurred
ithin  30  days  or  more  after  the  time  of  the  proce-
ure,  respectively.  Concerning  the  overall  complications,
he  elective  surgery  after  stenting  group’s  complications
ncluded  those  related  to  the  SEMS  placement,  elec-
ive  surgery  and  subsequent  bowel  reconstruction/recovery
urgeries.  Regarding  the  urgent  surgery  group,  the  over-
ll  complications  included  all  those  after  urgent  surgery
nd  subsequent  surgeries  and  ultimately  bowel  reconstruc-
ion/recovery.
Mortality  was  assessed  as  procedure-related  death,
ccurring  30  days  after  intervention  and  as  overall  mortal-
ty  during  follow-up.  Overall  survival  was  calculated  as  the
ime  interval  from  the  date  of  the  SEMS  insertion  or  urgent
urgery  until  the  date  of  death  or  of  the  last  follow-up.  The
verall  length  of  hospital  stay  included,  for  each  patient,
he  number  of  days  as  an  inpatient  during  follow-up  (acute
rocedures,  surgeries,  complications  management).
As  major  outcome  measurements  for  analytical  compar-
son  of  colonic  stenting  vs.  urgent  surgery,  we  considered
he  overall  rates  of  clinical  success,  primary  anastomosis,
olostomy  rate,  complications,  hospital  stay,  mortality  rate
nd  overall  survival.
.6.  Statistical  analysis
tatistical  analysis  was  performed  using  the  Statistical
ackage  for  Social  Sciences® (SPSS)  software.In  order  to  compare  SEMS  as  a  bridge-to-surgery  vs.
alliative  SEMS  and  SEMS  placement  vs.  urgent  surgery,  Stu-
ent’s  t  test  (t)  or  Wilcoxon-Mann--Whitney  test  (Z)  was  used
or  quantitative  variables  (presented  as  mean  ±  standard
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deviation  (SD))  and  chi-square  test  (X2)  or  Fisher’s  exact
test  were  used  for  qualitative  variables.  The  Kaplan--Meier
method  was  performed  to  estimate  median  survival  times
of  the  SEMS  and  urgent  surgery  groups  and  the  receiver
operating  characteristics  (ROC)  curve  analysis  was  under-
taken  to  identify  a  potential  optimal  threshold  time  to
perform  elective  surgery  after  SEMS  placement.  The  binary
logistic  regression  model  was  applied  to  evaluate  risk
factors  related  to  overall  complications  and  mortality  after
treatment  of  acute  malignant  colorectal  occlusion.
A  p  value  less  than  or  equal  to  0.05  was  considered  to  be
statistically  signiﬁcant.
3. Results
Between  January  2005  and  March  2013,  189  patients  were
diagnosed  with  malignant  colorectal  occlusion  of  which  12
were  immediately  excluded  (seven  from  another  hospital,
without  follow-up  details  and  ﬁve  with  speciﬁc  exclusion
criteria).  Thus,  the  population  of  this  study  included  177
patients,  85  of  which  underwent  SEMS  placement  and  92
urgent  surgery.  In  ﬁve  patients  proposed  for  SEMS  as  a
bridge-to-surgery,  stenting  was  not  possible  due  to  tech-
nical  reasons;  this  was  considered  in  the  SEMS  technical
success  calculations.  However,  in  the  general  analysis  these
patients  ended  up  in  the  urgent  surgery  group.  Therefore,  on
the  SEMS  group,  35  were  performed  as  a  bridge-to-surgery
and  50  as  a  deﬁnitive  treatment  (palliation).  In  the  group
f
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ptients’  management.
f  patients  who  underwent  urgent  surgery,  the  tumor  was
esected  in  71  by  colectomy  with  primary  anastomosis  or
artmann’s  procedure,  while  21  underwent  only  decompres-
ive  colostomy/ileostomy  (palliation).  Fig.  1  presents  the
owchart  of  the  patients’  management.
.1.  Demographic,  clinical  characteristics  and
umor features
he  descriptive  and  global  comparative  analysis  of  the  pop-
lation  studied  (two  main  groups)  is  presented  in  Table  1.
here  were  no  noteworthy  differences  in  patient  character-
stics  or  outcome  between  malignant  occlusion  treated  in
raga  Hospital  and  ULSAM.
Patients  undergoing  SEMS  placement  were  older  (73  vs.
8  years,  p  =  0.006)  and  more  likely  to  have  Diabetes  mel-
itus  (43%  vs  22%,  p  =  0.011)  or  cardiovascular  disease  (33%
s.  13%,  p  = 0.009).  On  the  other  hand,  patients  submitted  to
rgent  surgery  had  more  severe  anemia  (15%  vs  0%,  p  =  0.049)
nd  higher  CRP  values  (84%  vs  50%,  p  =  0.010).  Most  patients
resented  complete  occlusion  (67%)  of  the  left  colon  (83%).
owever,  the  right  colon  was  more  frequently  approached
y  surgery.  The  Dukes  classiﬁcation  was  also  signiﬁcantly  dif-
erent  between  the  two  groups:  D  stage  was  more  frequent
n  the  SEMS  group  (50%)  and  B  stage  in  the  urgent  surgery
roup  (39%).  This  was  to  be  expected,  considering  the  pur-
ose  of  treatment:  mainly  palliative  in  patients  undergoing
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Table  1  Demographic,  clinical  characteristics  and  tumor  features  of  patients  with  malignant  colorectal  occlusion.
Outcomes  Totala
(n  =  177)
SEMS
(n  =  85)
Urgent  surgery
(n =  92)
p  Value
Demographic  characteristics
Age  (years),  mean  ±  Standard
deviation  (range)
70.5  ±  13.0  (34--95)  73.3  ±  11.8  (46--95)  68.0  ±  13.5  (34--91)  0.006
Gender, n  (%)
Male  108  (61.0)  53  (62.4)  55  (59.8)  0.726
Female 69  (39.0)  32  (37.6)  37  (40.2)
Average BMI  ±  SD:  kg/m2 (range)  24.1  ±  5.0  (14.9--39.1)  24.7  ±  4.8  (14.9--35.9)  25.1  ±  5.1  (17.7--39.1)  0.690
Clinical characteristics
Medical  comorbidities,  n  (%)b 122  (69.7) 58  (59.0) 64  (70.3) 0.854
Hypertension  91  (64.1) 50  (67.6) 41  (60.3) 0.367
Diabetes Mellitus  40  (31.7)  25  (43.1)  15  (22.1)  0.011
Cardiovascular  disease  28  (22.2)  19  (32.8)  9  (13.2)  0.009
Pulmonary disease 14  (11.1)  6  (10.3)  8  (11.8)  0.800
Renal disease 10  (7.9)  7  (12.1)  3  (4.4)  0.185
Gastrointestinal  disease 24  (19.0)  9  (15.5)  15  (22.1)  0.351
ASA scoring,  n  (%) 0.354
I  12  (9.4) 4  (10.5) 8  (8.9)
II 57  (44.5) 21  (55.3)  36  (40.0)  0.049
III 39  (30.5) 8  (21.1) 31  (34.4)
IV 20  (15.6) 5  (13.2)  15  (16.7)  0.066
Blood parameters,  n  (%)
Anemia  (Hb  <  13  g/dL  --  in  men;
Hb <  12  g/dL  -- in  women)
46  (39.7) 12  (38.7) 34  (40.0) 0.010
Severe anemia  (Hb  <8  g/dL)  13  (11.2)  0  13  (15.3)
Leucocytosis  (>10.000)  32  (29.6)  3  (13.6)  29  (33.7)
CRP increase  (>2.50  mg/dL)  46  (74.2)  9  (50.0)  37  (84.1)
Tumor features
Location,  n  (%)  0.001
Left colon  146  (82.5)  77  (90.6)  69  (75.0)
Transverse  colon  14  (7.9)  7  (8.2)  7  (7.6)  0.061
Right colon  17  (9.6)  1  (1.2)  16  (17.4)
Type of  occlusion,  n  (%)  0.011
Complete 113  (67.3)  48  (60.0)  65  (73.9)
Partial 55 (32.7)  32  (40.0)  23  (26.1)
Dukes classiﬁcation,  n  (%)
A 1  (0.6)  1  (1.2)  0
B 54  (32.7)  22  (26.8)  32  (38.6)
C 46  (27.9)  18  (22.0)  28  (33.7)
D 64  (38.8)  41  (50.0)  23  (27.7)
Treatment purpose  0.001
Curative, n  (%)  106  (59.9)  35  (41.2)  71  (77.2)
Palliative, n  (%)  71  (40.1)  50  (58.8)  21  (22.8)
a Total-group that underwent SEMS placement plus group that underwent urgent surgery.
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EMS  placement  (59%)  and  curative  in  patients  submitted  to
rgent  surgery  (77%).
.2.  Procedure  details  and  analysis.2.1.  Global  SEMS  placement  (bridge-to-surgery  and
alliative)
echnical  success  was  obtained  in  94%  (85/90)  of  patients  in
hom  SEMS  placement  was  attempted  (Table  2).  Technical
S
l
i
6ailure  occurred  in  ﬁve  patients  with  complete  occlusion  and
ubsequent  inability  to  pass  the  guide  wire.
Colon  decompression  associated  to  symptom  relief  was
aintained  without  any  complication  or  need  for  reinter-
ention  in  70%  of  the  patients  until  elective  surgery  in  the
EMS  as  a  bridge-to-surgery  group  or  up  to  death  in  the  pal-
iative  group.  The  clinical  success  was  signiﬁcantly  higher
n  patients  undergoing  SEMS  as  a  bridge-to-surgery  (83%  vs
0%,  p  =  0.024).  SEMS  occlusion  was  the  most  frequent  late
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Table  2  Comparison  of  the  two  main  groups  of  SEMS  placement  (SEMS  as  bridge-to-surgery  vs  palliative  SEMS).
Outcomes  Total
(n  =  85)
SEMS  as
bridge-to-surgery
(n  =  35)
Palliative
SEMS
(n  =  50)
p  Value
Technical  success,  n  (%)  85  (94.4)  −  --  −
Clinical success,  n  (%)  59  (69.4)  29  (82.9)  30  (60.0)  0.024
Complications,  n  (%)a 26  (30.6)  6  (17.1)  20  (40.0)  0.024
Stent occlusion 16  (18.8)  3  (8.6)  13  (26.0)  0.043
Stent migration 8  (9.4) 3  (8.6) 5  (10.0) 1.000
Bowel perforation 6  (7.1) 0  6  (12.0) 0.040
Early complications,  n
(%)
12  (44.4) 3  (50.0) 9  (42.9) 1.000
Late complications,  n  (%)  16  (59.3)  3  (50.0)  13  (61.9)  0.662
Reinterventions,  n  (%)  26  (30.6)  6  (17.1)  20  (40.0)  0.024
Urgent surgery  11  (42.3)  1  (16.7)  10  (50.0)  0.197
Stent reinsertion 15  (57.7) 5  (83.3) 10  (50.0) 0.197
Mortality, n  (%)
30-day  mortality 8  (16.3) 1  (10.0) 7  (17.9) 1.000
Overall mortality 49  (61.3) 10  (31.3) 39  (81.3) 0.001
Survival (days),
mean  ±  SD  (range)
853.3  ±  125.8  (2--2684)  1620.4  ±  237.2  (18--2684)  421.3  ±  83.9  (2--1931)  0.001
Stent patency  (days),
mean  ±  SD  (range)
--  --  154.5  ±  151.8  (1--553)  --
Time to  surgery  (days),
mean  ±  SD  (range)
--  21.1  ±  18.7  (3--77)  --  --
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complication  (19%),  followed  by  SEMS  migration  (9%).  Bowel
perforation  was  less  frequent  (7%),  occurring  shortly  after
the  endoscopic  procedure.  The  stents  and  respective  num-
bers  used  were  Wallﬂex® (45)  Hanarostent® (32),  Wallstent®
(3),  Ultraﬂex  (3)  and  Evolution® (2).  We  found  no  differences
in  their  use  between  bridge-to-surgery  and  palliative  pur-
poses  and,  in  a  general  analysis,  no  signiﬁcant  differences
related  to  clinical  success  or  complication  rate  between
them  were  found.
In  ﬁve  of  six  patients  with  SEMS  as  a  bridge-to-surgery,
the  complication  was  solved  by  insertion  of  a  new  SEMS
while  in  patients  with  palliative  SEMS  the  complication  was
solved  endoscopically  in  half  of  the  cases  and  surgically  in
the  other  half.  In  SEMS  as  a  bridge-to-surgery,  the  average
time  elapsed  between  SEMS  placement  and  elective  surgery
was  21  days.  The  ROC  curve  analysis  could  not  identify  the
most  favorable  time  between  SEMS  placement  and  elective
surgery  (area  under  the  ROC  curve  0.465).  The  patency  of
SEMS  in  the  palliation  group  was  ﬁve  months,  which  was  sig-
niﬁcantly  lower  than  the  average  time  of  survival  of  these
patients  (14  months).
3.2.2.  Elective  surgery  after  SEMS  placement  vs.  urgent
surgery
The  comparative  analysis  between  these  two  main  groups
is  presented  in  Table  3.  Concerning  clinical  success,  no
signiﬁcant  differences  were  observed  between  the  groups,
although  it  was  slightly  higher  in  the  elective  surgery  group.The  segmental  colectomy  was  the  most  frequent
approach,  both  in  the  elective  surgery  after  SEMS  group
(86%)  and  in  the  urgent  surgery  group  (59%).  However,
patients  submitted  to  urgent  surgery  presented  a  higher
c
t
rumber  of  Hartmann’s  (41%  vs  14%,  p  =  0.006)  and  thus  a
igher  number  of  stoma  (55%  vs  26%,  p  =  0.004),  while  most
atients  that  underwent  elective  surgery  after  SEMS  had  a
ne-stage  surgery  and  therefore  having  primary  anastomosis
n  the  majority  of  situations  (94%  vs.  76%,  p  =  0.038).
Regarding  postoperative  complications,  there  was  a
rend,  not  statistically  signiﬁcant,  for  a  higher  occurrence
n  patients  undergoing  urgent  surgery  (peritonitis,  with  or
ithout  septic  shock,  intra-abdominal  abscess  and  anasto-
otic  leakage  were  the  most  common).  Concerning  overall
omplications  (abdominal  and  extra-abdominal)  we  did  not
nd  signiﬁcant  differences.  The  urgent  surgery  carried  more
lood  transfusions  during  surgery  and  the  patients  were  also
ore  frequently  admitted  in  the  intensive  care  unit  (ICU),
lthough  this  was  not  statistically  signiﬁcant.
The  hospital  stay  was  longer  in  the  elective  surgery  after
EMS  group.  However,  total  hospital  stay  and  costs  for  rein-
erventions  or  late  complications  in  the  emergency  surgery
roup  were  superior.
When  analyzing  mortality  results,  procedure-related
ortality  was  not  signiﬁcantly  different  between  the  two
roups,  but  overall  mortality  was  signiﬁcantly  higher  in  the
rgent  surgery  group  (57%  vs  31%,  p  =  0.020).
Concerning  the  overall  complications,  the  logistic  model
Table  4) identiﬁed  patients’  age  and  CRP  levels  as  predictive
isk  factors:  the  increase  of  ﬁve  years  of  age  was  associ-
ted  with  a  3.3  higher  risk  of  complications,  and  patients
ith  increased  CRP  values  were  10.5  times  more  prone  to
omplications.
Concerning  mortality,  the  logistic  model  (Table  5)  iden-
iﬁed  patients’  age  and  the  acute  approach  as  predictive
isk  factors:  the  increase  of  ﬁve  years  of  age  and  the  urgent
72  D.  Fernandes  et  al.
Table  3  Comparison  of  outcomes  obtained  with  elective  surgery  after  SEMS  placement  vs.  urgent  surgery.
Outcomes  Total
(n  =  106)
Elective  surgery  after
SEMS  placement
(n  =  35)
Urgent
surgery
(n  =  71)
p
Clinical  success,  n  (%)  84  (79.2)  28  (80.0)  55  (77.5)  0.766
Type of  surgery,  n  (%)  0.006
Hartmann’s  procedure  34  (32.1)  5  (14.3)  29  (40.8)
Segmentectomy  72  (67.9)  30  (85.7)  42  (59.2)  0.038
Primary anastomosis  72  (82.8)  30  (93.8)  42  (76.4)
Colostomy  rate,  n  (%)  48  (45.3)  9  (25.7)  39  (54.9)  0.004
Postoperative
complications,  n  (%)a
45  (42.5) 12  (34.3) 33  (46.5) 0.232
Early complication,  n  (%) 38  (82.6) 9  (75.0) 29  (85.3) 0.412
Late complication,  n  (%)  15  (32.6)  3  (25.0)  12  (35.3)  0.513
Overall complications,  n
(%)
53  (50.0)  16  (45.7)  37  (52.1)  0.536
Reinterventions,  n  (%)  23  (21.7)  7  (20.0)  16  (22.5)  0.766
Emergent surgery  21  (87.5)  5  (62.5)  16  (100)  0.028
Elective surgery  4  (16.7)  2  (25.0)  2  (12.5)  0.578
Hospital stay  (days),
mean  ±  SD  (range)
23.37  ±  26.05  (1--179)  25.9  ±  20.3  (1--91)  22.2±  28.4  (2--179)  0.034
Mortality, n  (%)
30-day  mortality  8  (18.2)  1  (10.0)  7  (20.6)  0.659
Overall mortality  44  (47.8)  10  (31.3)  34  (56.7)  0.020
a More than one patient had more than one complication.
Table  4  Predictors  of  overall  complications  in  patients
with curative  purpose  (patients  who  experienced  elective
surgery  after  SEMS  placement  and  patients  submitted  to
urgent  surgery).
Variables  P  Exp  (B)a
Type  of  acute  treatment  0.750  1.267
Age 0.008  3.3
Medical  comorbidities  0.093  0.255
CRP increase  0.009  10.462
a Exp (B) -- exponentiation of the B coefﬁcient, which is an
odds ratio.
Table  5  Predictors  of  mortality  in  patients  with  curative
purpose.
Variables  P  Exp  (B)
Age  0.008  1.4
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aMedical  comorbidities  0.753  1.185
Type of  acute  treatment  0.006  4.016
urgery  were  associated  with  a  1.4  and  a  four  higher  risk  of
eath  respectively,  when  compared  with  SEMS  group.  The
edical  comorbidities  were  not  revealed  to  be  a  predictive
isk  factor.
.2.3.  Palliative  SEMS  vs.  Urgent  surgery
decompressive  colostomy)
n  palliative  treatment,  urgent  surgery  obtained  a  higher
linical  success  than  palliative  SEMS,  although  these  results
ere  not  statistically  signiﬁcant  (81%  vs  60%,  p  =  0.089)
v
W
-
rTable  6).  Palliative  SEMS  was  associated  with  more
omplications  and  therefore  more  reinterventions  (out  of  19
atients,  11  were  submitted  to  surgery  and  eight  to  inser-
ion  of  new  SEMS)  and  a  longer  hospital  stay.  These  two  last
utcomes  were  statistically  signiﬁcant.  The  percentage  of
atients  treated  with  chemotherapy  was  not  signiﬁcantly
ifferent  when  comparing  both  groups  (35%  in  the  SEMS
roup  and  29%  in  the  urgent  surgery  group).  Regarding  mor-
ality,  no  statistically  signiﬁcant  differences  were  observed
etween  the  two  groups,  although,  once  again,  the  urgent
urgery  group  presented  a  slightly  higher  mortality.
. Discussion
he  aim  of  this  study  was  to  assess  and  compare  the
isk/beneﬁt  ratio  of  SEMS  colorectal  placement  vs.  urgent
urgery  in  the  treatment  of  acute  colorectal  occlusion,
ither  with  a  curative  or  palliative  purpose.
Regarding  the  SEMS  group,  the  endoscopic  procedure  was
erformed  in  41%  of  patients  as  a  bridge-to-surgery  and
n  59%  of  patients  as  a  palliative  approach.  We  obtained
 technical  success  of  94%,  which  is  consistent  with  the
iterature.5,14,18,20 The  clinical  success  in  SEMS  as  bridge-to-
urgery  was  signiﬁcantly  higher  when  compared  to  palliative
EMS  (83%  vs  60%).  In  published  data,  the  clinical  suc-
ess  in  SEMS  as  a  bridge-to-surgery  presents  similar  values
69--94%),6,18,21 while  in  palliative  SEMS  the  values  reported
re  76--93%.5,22.  This  difference  may  be  explained  by  the
ariable  deﬁnition  of  clinical  success  in  different  studies.
e  consider  the  same  deﬁnition  for  both  SEMS  subgroups
-  obstructive  symptom  relief,  without  any  complications
equiring  endoscopic  or  surgical  reintervention  --  and,  as
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Table  6  Comparison  of  outcomes  obtained  with  palliative  SEMS  vs.  decompressive  colostomy.
Outcomes  Total
(n  =  71)
Palliative
SEMS
(n  =  50)
Decompressive
colostomy/ileostomy
(n  =  21)
p
Clinical  success,  n  (%)  47  (66.2)  30  (60.0)  17  (81.0)  0.089
Complications,  n  (%)a 26  (36.6)  20  (40.0)  6  (28.6)  0.362
Early complications,  n  (%)  12  (44.4)  9  (42.9)  3  (50.0)  1.000
Late complications,  n  (%)  16  (59.3)  13  (61.9)  3  (50.0)  0.662
Reinterventions,  n  (%)  20  (29.0)  19  (40.4)  1  (5.0)  0.004
Colostomy rate,  n  (%)  32  (41.1)  11  (22.0)  21  (100)  0.001
Chemotherapy
administration,  n  (%)
23  (32.9) 17  (34.7) 6  (28.6) 0.617
ICU, n  (%) 2  (2.8) 2  (4.0) 0  1.000
Hospital stay  (days),
mean  ±  SD  (range)
12.6  ±  10.5  (1--51)  14.9  ±  11.6  (1--51)  7.3  ±  4.3  (1--15)  0.004
Mortality, n  (%)
30-day  mortality  13  (23.2)  7  (17.9)  6  (35.3)  0.157
Overall mortality  56  (84.8)  39  (81.3)  17  (94.4)  0.264
Survival (days),  mean  ±  SD
(range)
294.7  ±  47.1  (1--1931)  296.3  ±  59.7  (2--1931)  290.9  ±  75.7  (1--848)  0.988
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would  be  expected,  this  has  shown  to  be  very  restrictive
in  the  case  of  palliative  SEMS,  with  longer  hospital  stay  and
a  higher  probability  of  complications  and  need  for  reinter-
vention.
After  SEMS  placement,  31%  of  the  patients  had
complications,  mainly  later  ones.  These  data  are  consistent
with  some  studies  reporting  complication  rates  between
21  and  34%.5,8,16 However,  the  complication  rate  in  the
palliative  patients  was  higher  (40%),  probably  due  to  the
previously  mentioned  reason.  It  is  also  suggested  that  the
operator’s  technical  experience8,23--25 and  the  endoscopic
device  characteristics26,27 can  inﬂuence  the  procedure’s
safety  and  accuracy.  In  our  study  the  endoscopist  was  not
always  the  same  but  was  always  experienced  and  the  dif-
ferent  stents  used  did  not  present  signiﬁcant  differences  in
the  main  outcome  --  clinical  success.
In  patients  treated  with  a  curative  purpose,  the  clin-
ical  success  obtained  in  SEMS  as  a  bridge-to-surgery  was
slightly  higher,  compared  to  the  urgent  surgery  group.  This
result  is  supported  by  several  studies  reporting  higher  clin-
ical  success  rates  after  SEMS  placement,6,8,21,28,29 although
a  recent  meta-analysis  revealed  signiﬁcantly  higher  clini-
cal  success  rates  in  the  urgent  surgery.7 In  addition,  the
SEMS  group  obtained  a  signiﬁcantly  higher  number  of  pri-
mary  anastomosis,  associated  to  a  signiﬁcant  reduction  in
colostomy  rate,  as  reported  by  other  authors.3,7,8,13,14,25,30
In  the  literature  some  advantages  of  primary  anastomosis  in
one-stage  are  pointed  out,  speciﬁcally,  the  decrease  of  hos-
pital  costs  and  complications  associated  to  colostomy  and
also  avoiding  the  risks  of  a  second  intervention.9 Although
few  studies  evaluated  the  impact  that  each  procedure  has
in  the  patients’  quality  of  life,  the  colostomy  has  been  asso-
ciated  with  anxiety,  depression,  sleep  alterations  and  social
reclusion,6,31,32,34 features  that  can  be  overcome  by  an  elec-
tive  surgery  preceded  by  stenting.
When  analyzing  postoperative  complications,  we  did
not  identify  signiﬁcant  differences  between  the  two
p
h
t
wroups,  even  though  elective  surgery  presented  fewer
omplications.  This  is  probably  due  to  a  lesser  preoperative
isk  associated  with  the  gap  time  between  SEMS  place-
ent  and  surgery,  allowing  a  proper  clinical  evaluation,
etter  bowel  conditions  and  nutritional  optimization,  as  sup-
orted  by  other  publications.1,7,8,21 Even  though,  there  are
ome  studies 8,21 suggesting  an  optimum  time  between  SEMS
lacement  and  elective  surgery  around  six  and  14  days,
e  were  not  able  to  consistently  deﬁne  the  appropriate
ap  time  in  this  analysis.21 The  elective  surgery  was  per-
ormed,  in  average,  21  days  after  the  stent  placement,
hich  may  have  contributed  to  an  unexpected  higher  num-
er  of  complications  in  this  group.
When  comparing  other  important  outcomes,  urgent
urgery  patients  required  more  ICU  admittance  and  more
einterventions  due  to  postoperative  complications.  This
roup  also  presented  a  non-statistical  trend  toward  a  higher
eed  of  blood  transfusion.  The  two  single  studies  reporting
hese  variables  are  in  agreement  with  our  results.34,35 After
he  acute  procedure,  the  discharge  occurred  earlier  in  the
EMS  group,  but  the  global  hospital  stay  was  longer  due  to
einterventions.  Despite  the  longer  hospital  stay  of  patients
ubmitted  to  stenting  as  a  bridge-to-surgery,  this  procedure
eems  to  be  more  effective  and  associated  with  12--20%
ess  costs  than  the  urgent  surgery,36--38 which  may  be  sub-
tantiated  by  the  lower  ICU  admittance  and  reintervention
ates.
To  our  knowledge,  few  studies  compare  the  palliation
pproaches  --  acute  palliative  SEMS  and  decompressive
olostomy/ileostomy  --  and  have  contradictory  ﬁndings.  Our
esults  suggest  that  palliative  SEMS  does  not  have  a  signif-
cant  advantage  over  palliative  surgery  for  decompressing
nresectable  malignant  colorectal  occlusion  because  some
atients  had  higher  survival  than  expected  and  consequently
ad  more  complications  and  signiﬁcantly  more  need  for  rein-
erventions  and  a  hospital  stay.  This  ﬁnding  is  consistent
ith  a  previous  study  also  revealing  higher  complications
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ate  in  SEMS  used  in  patients  with  advanced  and  metastatic
olon  cancer  six  months  after  SEMS  placement.  Neverthe-
ess,  the  author  added  and  we  conﬁrm,  that  part  of  these
EMS  complications  can  be  managed  by  stent  replacement,
ithout  a  signiﬁcant  increase  in  morbidity  and  mortality.39
n  the  other  hand,  a  recent  meta-analysis,40 demonstrates
hat  SEMS  is  as  effective  as  surgery,  with  shorter  hospital
tay,  quicker  recovery  and  comparable  risk  of  short-term
omplications  and  mortality.  However,  these  are  mainly
hort-term  outcomes  and  the  study  also  showed  a  higher
isk  of  long-term  complications  with  SEMS.  Liang  et  al.40
onﬁrmed  a  general  problem  among  the  studies  found  in
iterature,  remarking  that  the  lack  of  data  or  the  greater
eterogeneity  in  primary  studies  precluded  the  analysis  of
ther  outcomes  such  as  readmission  and  survival  time.
Concerning  the  limitations  of  this  study,  the  most  impor-
ant  were  the  retrospective  and  therefore  nonrandomized
nd  uncontrolled  design.  It  prevents  us  from  having  groups
ith  similar  population  samples  and  characteristics,  which
an  consequently  bias  the  results.  Additionally,  we  were
ot  able  to  reliably  evaluate  the  inﬂuence  of  the  operator’s
xperience  in  the  obtained  surgical  outcomes.
. Conclusion
EMS  placement  as  a  bridge-to-surgery  should  be  considered
n  the  acute  treatment  of  malignant  colorectal  occlusion,
here  it  seems  to  be  an  effective  and  safer  procedure,
ssociated  with  a  higher  primary  anastomosis  rate  and,  con-
equently,  a  lower  colostomy  rate,  number  of  complications
nd  procedure-related  mortality.
SEMS  placement  as  palliative  treatment  does  not  seem
o  present  signiﬁcant  clinical  advantages  comparatively  to
ecompressive  colostomy/ileostomy  when  treating  an  unre-
ectable  malignant  occlusion  and  the  longer  the  SEMS  stays
n  place  the  higher  is  the  risk  of  complications.  So,  unless
he  patient  obstinately  refuses  the  idea  of  having  a  stoma,
atients  with  advanced  local  disease,  but  good  general
ondition,  in  which  a  slightly  longer  survival  is  expected,
urgery  may  be  the  best  option.  However,  further  studies
omparing  the  two  possible  approaches  of  malignant  colonic
cclusion  are  needed,  especially  prospective  and  random-
zed  ones.  It  will  also  be  important  to  evaluate  the  impact
f  each  procedure  on  the  patients’  quality  of  life.
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